LLY was just upgraded by UA (underground stock alerts- google them ) to a BUY with a new price target, LOOK WHAT IT IS!!! that’s HUGE. i’m subscribed to UA’s free newsletter, their subscriber base is huge, the last time they alerted a buy the stock ended up going up 1350% in a very short period, no way this will happen with our stock but it’s still very positive. i’ve made over $200k with their free alerts so far so it’s definitely not something to sneeze at.
The drugmaker told investors that foreign exchange rates and slower growth in some markets will make it difficult to meet its 2014 revenue goal.
I've been trading LLY very successfully, but I'm looking for a good research site to get stock picks from. I've made a lot of money (over $60k) from UA (underground stock alerts) google them - looking for more solid research sites to add to my trading arsenal. please leave your recommendations below along with a review, i think this will be beneficial to all traders here on the board. thanks and good luck to all! -Freddy
I hear that MNKD is looking to partner up for Afrezza if and when approved by the FDA.
The longer a BP waits the more they'll have to pay.
seems stomach cancer represents an unmet need as well, though LLY's antibody could not treat the her-2 negative breast cancer that Herceptin is not effective for either.
Albeit I wouldnt view it as negative news, it has kinda neutral outcome which seems the market do not like these days. But looking at opportunities elsewhere (other sectors) only Lilly makes some sense
Article says the drug ramucirumab didn't work on breast cancer but worked on stomach cancer and that Lilly was going to continue to develop it.
I wouldn't call that money wasted.
The Imclone antibodies don't work. Never did, never will. Over ten billion wasted, maybe 100 billion if you count lost opportunity costs. Colossal cluster you know what